Open AccessDynamic parameters of homeostasis under the influence of antiaggregant treatment in patients with atrial fibrillation and metabolic syndrome
Author(s) -
Mariya A. Orynchak,
М. М. Vasylechko
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.2.70.2014.75
Subject(s) - hemostasis , aspirin , atrial fibrillation , medicine , fibrinogen , platelet , polyunsaturated fatty acid , cardiology , arginine , coagulation , fatty acid , chemistry , amino acid , biochemistry
The condition of coagulation and platelet hemostasis in 125 patients with atrial fibrillation (AF) and with metabolic syndrome (MS) has been analysed. Сoagulation and platelet hemostasis in 125 patients with AF and MS under treatment with acetylsalicylic acid (ASA) (group 1), omega-3 polyunsaturated fatty acids (omega-3 PUFAs) (group 2) and ASA with L-arginine (3 group) during 2 months were measured. It was established that omega-3 PUFAs are more effective compared with ASA/aspirin with L-arginine and it promotes normalization of fibrinogen, soluble fibrin-monomer complexes (SFMK), D-dimer and improves the platelet aggregative activity (PAA).